Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerThe effect of oxythioquinox exposure on normal human mammary epithelial cell gene expression: a microarray analysis studyDifferential gene expression in normal human mammary epithelial cells treated with malathion monitored by DNA microarraysLigand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1Induction of cyclin D1 by simian virus 40 small tumor antigenRegulation of p16CDKN2 expression and its implications for cell immortalization and senescenceDifferent roles for cyclins D1 and E in regulation of the G1-to-S transitionEstrogen regulation of cyclin E2 requires cyclin D1 but not c-Mycleptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cellsPosttranscriptional regulation of cancer traits by HuRPI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cellsSchlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1.CycD1, a putative G1 cyclin from Antirrhinum majus, accelerates the cell cycle in cultured tobacco BY-2 cells by enhancing both G1/S entry and progression through S and G2 phases.Cyclins and breast cancer.Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.CAPER, a novel regulator of human breast cancer progression.Epithelial cell transforming sequence 2 in human oral cancer.c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.Fos family members induce cell cycle entry by activating cyclin D1.Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosisCyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes.Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in miceDown-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).Mechanisms of cyclin-dependent kinase inactivation by progestinsDifferential regulation of cyclin D1 expression by protein kinase C α and ϵ signaling in intestinal epithelial cells.Cyclin-dependent kinase inhibitors: novel anticancer agents.Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.Interview with the retinoblastoma family members: do they help each other?Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
P2860
Q21328702-4223192D-33D9-4A31-B879-94C8A572BB57Q23918082-80559A3E-ABC9-412A-85CD-86B570AC625AQ23918085-ECDCD53E-9AE3-4571-AB83-9517A3880163Q24595709-79E207F1-AF54-4992-8501-BE386234873EQ24648223-E545DD48-705A-4A04-9C2C-569D5E7692B2Q24650807-0EDF1896-ED47-4848-987C-C154E6EAC1A9Q24651978-32B74CA6-939A-4BC3-88E8-CFCFB7C19091Q24653031-4823E160-F1BF-4A7F-86D7-BD858D8D5E5BQ28115934-6999A8E2-D018-4C69-9C28-5097FAF229F3Q28213452-AC35DC69-C5FF-4E81-9E84-E23585460F44Q28246373-D461D137-3DAA-4094-9767-A7ED38E68C10Q28248667-A20BB673-AC52-4C8F-AED8-CB52D968480EQ28363087-1F3D0525-18E7-4468-95F4-C74B907FA0B9Q28508297-DAB51633-B9D0-4135-BEE9-4226DA6A0F15Q31957656-414D673A-DCB6-436A-9E0B-B62147053F3DQ33340320-4A9A9B2B-F4B4-40BF-BE7F-FA65D1D4CB46Q33538420-C73E9C76-A8E8-44A8-9632-50652166496AQ33674312-CD804CC3-8B33-4CEB-B7C6-C6419915ED1BQ33728372-7F6960D8-B296-4B89-ABE4-6D5DAD865B84Q33760669-3695CAA8-63C0-4BFC-B338-F01BEC83BF5DQ33775134-B9099188-D41C-4C07-B7D4-ACA860AE7E26Q33779543-6BAC541D-CB7A-4881-B700-6A959A712E55Q33837460-1AA18066-58F7-4CD1-BA75-083F852955C8Q33840107-B82B3B4A-5921-46B5-81F4-7FAD63700160Q33854336-6B756AE3-78CB-461B-8DEF-16583B281594Q33884776-EAD4EF9C-CA44-473E-9804-150FD4E2DFFAQ33888599-9DBCF108-5B1E-4645-9E59-E6D6504087F9Q33948380-61E59C40-3BE5-42F6-8DD8-10B504E2BEF3Q33951820-7E9B1410-1FFD-4F7F-A4DD-642968402800Q33957539-11662EDD-108C-459E-81E0-9B172DBD8B1FQ33966174-32EE4D8F-49C9-4616-93D4-C01537CCA4EBQ33969345-7847E60B-35B6-4DDD-83D5-29CCE6E644D8Q33993962-AC557551-5375-43F5-BA9B-FBFFF0B8846EQ34070434-B31E0347-270D-4934-A51A-E3721B1FE781Q34075028-FB4A30C4-42B0-4CE6-9D03-8B86EAE7DFA8Q34332592-57803467-DD54-498B-BF5C-22C5140C7AECQ34424883-AEED4F44-BE11-4CDD-B1B4-3323B9A4AECAQ34438994-B09F810C-6573-4CE7-8622-E9BD245723C1Q34736677-36312720-CAF9-4661-86F9-B0D4DFE3977DQ34902476-88D87A6C-6D4F-48CD-AD3D-EA1DA14B7292
P2860
Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@ast
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@en
type
label
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@ast
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@en
prefLabel
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@ast
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@en
P2093
P2860
P356
P1476
Cyclin D1 induction in breast ...... G1 to complete the cell cycle.
@en
P2093
Buckley MF
Musgrove EA
Sutherland RL
P2860
P304
P356
10.1073/PNAS.91.17.8022
P407
P577
1994-08-01T00:00:00Z